ARDELYX, INC. Other Non-Current Liabilities
ARDELYX, INC. (ARDX) had Other Non-Current Liabilities of $170.00 thousand as of 2023-09-30, per its 10-Q filed 2023-10-31.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2023-10-31
- 2023-09-30: Other Liabilities, Noncurrent $170.00K.
- 2023-06-30: Other Liabilities, Noncurrent $172.00K.
- 2022-12-31: Other Liabilities, Noncurrent $0.00.
- 2018-09-30: Other Liabilities, Noncurrent $651.00K.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2023-09-30 | $170.00K 10-Q · filed 2023-10-31 |
| 2023-06-30 | $172.00K 10-Q · filed 2023-08-02 |
| 2022-12-31 | $0.00 10-Q · filed 2023-10-31 |
| 2018-09-30 | $651.00K 10-Q · filed 2018-11-07 |
| 2018-06-30 | $677.00K 10-Q · filed 2018-08-07 |
| 2018-03-31 | $699.00K 10-Q · filed 2018-05-08 |
| 2017-12-31 | $720.00K 10-Q · filed 2018-11-07 |
| 2017-09-30 | $741.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | $756.00K 10-Q · filed 2017-08-09 |
| 2017-03-31 | $767.00K 10-Q · filed 2017-05-05 |
| 2016-12-31 | $779.00K 10-Q · filed 2017-11-07 |
| 2016-09-30 | $789.00K 10-Q · filed 2016-11-07 |
| 2016-06-30 | $713.00K 10-Q · filed 2016-08-08 |
| 2016-03-31 | $292.00K 10-Q · filed 2016-05-09 |
| 2015-12-31 | $322.00K 10-K · filed 2017-02-17 |
| 2015-09-30 | $352.00K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $382.00K 10-Q · filed 2015-08-12 |
| 2015-03-31 | $297.00K 10-Q · filed 2015-05-12 |
| 2014-12-31 | $122.00K 10-K · filed 2016-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |